Department of Internal Medicine V - Pulmonology, Allergology, Critical Care Care Medicine, Saarland University Hospital, Homburg, Germany.
Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig Maximilians University (LMU), Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.
Sci Rep. 2020 Jun 29;10(1):10544. doi: 10.1038/s41598-020-67197-x.
We studied whether in patients with stable COPD blood gases (BG), especially oxygenated hemoglobin (OxyHem) as a novel biomarker confer information on disease burden and prognosis and how this adds to the information provided by the comorbidity pattern and systemic inflammation. Data from 2137 patients (GOLD grades 1-4) of the baseline dataset of the COSYCONET COPD cohort were used. The associations with dyspnea, exacerbation history, BODE-Index (cut-off ≤2) and all-cause mortality over 3 years of follow-up were determined by logistic and Cox regression analyses, with sex, age, BMI and pack years as covariates. Predictive values were evaluated by ROC curves. Capillary blood gases included SaO, PaO, PaCO, pH, BE and the concentration of OxyHem [haemoglobin (Hb) x fractional SaO, g/dL] as a simple-to-measure correlate of oxygen content. Inflammatory markers were WBC, CRP, IL-6 and -8, TNF-alpha and fibrinogen, and comorbidities comprised a broad panel including cardiac and metabolic disorders. Among BG, OxyHem was associated with dyspnoea, exacerbation history, BODE-Index and mortality. Among inflammatory markers and comorbidities, only WBC and heart failure were consistently related to all outcomes. ROC analyses indicated that OxyHem provided information of a magnitude comparable to that of WBC, with optimal cut-off values of 12.5 g/dL and 8000/µL, respectively. Regarding mortality, OxyHem also carried independent, additional information, showing a hazard ratio of 2.77 (95% CI: 1.85-4.15, p < 0.0001) for values <12.5 g/dL. For comparison, the hazard ratio for WBC > 8000/µL was 2.33 (95% CI: 1.60-3.39, p < 0.0001). In stable COPD, the concentration of oxygenated hemoglobin provided additional information on disease state, especially mortality risk. OxyHem can be calculated from hemoglobin concentration and oxygen saturation without the need for the measurement of PaO. It thus appears well suited for clinical use with minimal equipment, especially for GPs.
我们研究了在稳定期 COPD 患者中,血液气体(BG),尤其是氧合血红蛋白(OxyHem)作为一种新型生物标志物,是否可以提供有关疾病负担和预后的信息,以及它如何补充共病模式和全身炎症提供的信息。使用了 COSYCONET COPD 队列基线数据集的 2137 名患者(GOLD 分级 1-4)的数据。通过逻辑回归和 Cox 回归分析确定与呼吸困难、恶化史、BODE 指数(截断值≤2)和 3 年随访期间全因死亡率的相关性,性别、年龄、BMI 和包年数作为协变量。通过 ROC 曲线评估预测值。毛细血管血气包括 SaO、PaO、PaCO、pH、BE 和 OxyHem 浓度[血红蛋白(Hb)x 分数 SaO,g/dL]作为氧含量的简单测量指标。炎症标志物包括 WBC、CRP、IL-6 和-8、TNF-α和纤维蛋白原,合并症包括包括心脏和代谢紊乱在内的广泛面板。在 BG 中,OxyHem 与呼吸困难、恶化史、BODE 指数和死亡率相关。在炎症标志物和合并症中,只有 WBC 和心力衰竭与所有结局始终相关。ROC 分析表明,OxyHem 提供的信息量与 WBC 相当,最佳截断值分别为 12.5 g/dL 和 8000/μL。关于死亡率,OxyHem 也提供了独立的附加信息,对于值<12.5 g/dL,风险比为 2.77(95%CI:1.85-4.15,p<0.0001)。相比之下,WBC>8000/μL 的风险比为 2.33(95%CI:1.60-3.39,p<0.0001)。在稳定期 COPD 中,氧合血红蛋白的浓度提供了有关疾病状态的附加信息,特别是死亡风险。OxyHem 可以根据血红蛋白浓度和氧饱和度计算得出,而无需测量 PaO。因此,它似乎非常适合临床使用,需要的设备最少,特别是对于全科医生。